1. Home
  2. LEGN vs FND Comparison

LEGN vs FND Comparison

Compare LEGN & FND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • FND
  • Stock Information
  • Founded
  • LEGN 2014
  • FND 2000
  • Country
  • LEGN United States
  • FND United States
  • Employees
  • LEGN N/A
  • FND N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • FND RETAIL: Building Materials
  • Sector
  • LEGN Health Care
  • FND Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • FND Nasdaq
  • Market Cap
  • LEGN 6.7B
  • FND 8.6B
  • IPO Year
  • LEGN 2020
  • FND 2017
  • Fundamental
  • Price
  • LEGN N/A
  • FND $89.73
  • Analyst Decision
  • LEGN Strong Buy
  • FND Hold
  • Analyst Count
  • LEGN 12
  • FND 17
  • Target Price
  • LEGN $73.36
  • FND $91.00
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • FND 2.3M
  • Earning Date
  • LEGN 11-11-2025
  • FND 10-29-2025
  • Dividend Yield
  • LEGN N/A
  • FND N/A
  • EPS Growth
  • LEGN N/A
  • FND N/A
  • EPS
  • LEGN N/A
  • FND 1.94
  • Revenue
  • LEGN $796,838,000.00
  • FND $4,600,232,000.00
  • Revenue This Year
  • LEGN $70.75
  • FND $6.49
  • Revenue Next Year
  • LEGN $52.47
  • FND $8.64
  • P/E Ratio
  • LEGN N/A
  • FND $46.44
  • Revenue Growth
  • LEGN 74.75
  • FND 4.88
  • 52 Week Low
  • LEGN $27.34
  • FND $66.01
  • 52 Week High
  • LEGN $52.31
  • FND $124.68
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 43.57
  • FND 59.28
  • Support Level
  • LEGN $32.70
  • FND $88.07
  • Resistance Level
  • LEGN $34.71
  • FND $88.73
  • Average True Range (ATR)
  • LEGN 1.20
  • FND 2.62
  • MACD
  • LEGN 0.00
  • FND 0.62
  • Stochastic Oscillator
  • LEGN 41.08
  • FND 89.37

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.

Share on Social Networks: